Organ Transplantation in Patients with Intellectual Disabilities

Organ transplantation in individuals with intellectual disabilities has historically been approached with caution owing to concerns about postoperative care, adherence to treatment and ethical considerations surrounding consent. Recent developments challenge the notion that intellectual disability alone constitutes a barrier to transplantation. A growing body of evidence indicates that, when supported by structured care pathways and robust multidisciplinary teams, patients with cognitive impairments can achieve outcomes comparable to the general transplant population. Ethical frameworks now emphasise that decision-making capacity should be assessed individually rather than assumed absent on the basis of a diagnosis. The allocation of organs must balance principles of equity, utility and respect for personhood, ensuring that non-medical characteristics do not unduly influence candidacy. Practical models demonstrate that involving caregivers, tailored education and clear protocols for immunosuppressive management can mitigate perceived risks and support long-term graft survival. This shift reflects a broader move towards inclusivity in transplant medicine, recognising the rights of all patients to life-saving therapies irrespective of intellectual ability.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Organ Transplantation in Patients with Intellectual Disabilities publication trend

The graph below shows the total number of articles in organ transplantation in patients with intellectual disabilities across all publications each year (not limited to Nature Index journals).

Technical terms

Intellectual disability: A chronic condition characterised by significant limitations in intellectual functioning and adaptive behaviour, emerging before adulthood.
Decision-making capacity: The ability of an individual to understand relevant information, appreciate the consequences of choices and communicate a reasoned choice.
Allograft: A transplant of an organ or tissue between genetically non-identical members of the same species.
Immunosuppressive therapy: A regimen of medications used to inhibit the recipient’s immune response and prevent rejection of a transplanted organ.
Contraindication: A specific situation or condition in which a particular medical treatment is inadvisable owing to potential harm.

References

1. Inequitable Access to Transplants: Adults With Impaired Decision-Making Capacity. Transplant International (2022).
2. Kidney transplantation from a living donor to a mentally disabled recipient with bilateral angiomyolipomas—A case report. International Journal of Surgery Case Reports (2018).